SC
WST icon

Schubert & Co’s West Pharmaceutical WST Stock Holding History

Schubert & Co’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-18
Closed -$6.24K – 1539
2023
Q1 		$6.24K Buy
18
+6
+50% +$1.75K 0.01% 368
2022
Q4 		$2.82K Buy
12
+7
+140% +$1.66K ﹤0.01% 688
2022
Q3 		$1K Sell
5
-10
-67% -$3.05K ﹤0.01% 1311
2022
Q2 		$5K Buy
15
+6
+67% +$1.95K ﹤0.01% 396
2022
Q1 		$4K Sell
9
-1
-10% -$391 ﹤0.01% 233
2021
Q4 		$5K Buy
+10
New +$4.3K 0.01% 144

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

Schubert & Co's WST Position: Q2 2023 in Review

Schubert & Co sold out of West Pharmaceutical (WST) in Q2 2023, closing a stake of 18 shares — an estimated $6.24K sold.

Schubert & Co first reported a position in WST in Q4 2021 and held it in 6 quarters. The position peaked at $6.24K in Q1 2023. 734 funds tracked by Wall St. Rank hold WST as of Q2 2023.

  • Schubert & Co reported no remaining West Pharmaceutical position as of Q2 2023 after selling out during the quarter.
  • Schubert & Co sold 18 West Pharmaceutical shares in Q2 2023, an estimated $6.24K.
  • Schubert & Co first reported a position in West Pharmaceutical in Q4 2021 and held it in 6 quarters.
  • Schubert & Co's West Pharmaceutical position peaked at $6.24K in Q1 2023.
  • 734 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.